Clinical data | |
---|---|
Trade names | Migimide, others |
Other names | Methetharimide β,β-methylethylglutarimide |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.535 |
Chemical and physical data | |
Formula | C8H13NO2 |
Molar mass | 155.197 g·mol−1 |
3D model (JSmol) | |
Melting point | 127 °C (261 °F) |
| |
| |
(verify) |
Bemegride (trademarked as Megimide) is a central nervous system stimulant.[1] The drug was first made in 1911.[2] It has been used in hypnotic overdose.[1]
As with other chemoreceptor agonists, it is a potent emetic at doses above those normally used in management of barbiturate overdose although emesis and aspiration are a concern during treatment.
It is a controlled substance in some countries.[1]